Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,216 signal articles · 245 in last 24h · 114,971 total before filter · latest 1h ago
245last 24h
1836last 7d
302● bullish (7d)
167● bearish (7d)
205publishers
AllMacro321Earnings885M&A102Regulatory23Product17Analyst23
✕ clear all filtersticker: ^GSPCSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Two Reasons The Fed May Hike Today: Oil Prices And History (Live Coverage)
Investor's Business Daily16d agoneutral
Two Reasons The Fed May Hike Today: Oil Prices And History (Live Coverage)

As the Federal Reserve gets set to release its monetary policy update at 2 p.m. ET, followed a half hour later by Chairman Kevin Warsh's news conference, Wall Street is the unusual position of not knowing what will happen. Prior to Warsh, Wall Street has typically been near certain about what the Fed would do, reflected by markets pricing in around 90% or higher odds of the expected result. The S&P 500 is sharply lower ahead of the Fed reveal, amid rebounding oil prices and the ongoing sell-off in AI and chip names.

AI Stocks’ Loss Is London’s Gain
The Wall Street Journal16d agoneutral
AI Stocks’ Loss Is London’s Gain

U.K. stocks have been out in the cold for much of 2026. Without a buzzy AI stock to its name, the FTSE 100 index lagged global peers. But a rout in chip stocks seems to have heralded a change in fortunes for London's premier index.

S&P 500 Stocks: GEHC Revives, Humana Fades On Earnings
Investor's Business Daily16d agoneutral
S&P 500 Stocks: GEHC Revives, Humana Fades On Earnings

GE HealthCare Technologies ran at the top of the S&P 500 Wednesday morning, while Humana was among major laggards after both companies posted better-than-expected Q2 earnings signaling a return to profit growth. GEHC broke above its recent trading range that followed its dive on Q1 results. Wednesday's stock action was pretty much the reversal of what we've seen this year for GEHC and HUM, with medical equipment stocks among the market's worst-performing industry groups and managed-care stocks ranked in the top tier.

Teradyne Stock Jumps as Earnings Guidance Does the Seemingly Impossible—Impresses Wall Street
Barrons.com16d agobullish
Teradyne Stock Jumps as Earnings Guidance Does the Seemingly Impossible—Impresses Wall Street

It takes a lot for artificial-intelligence trade-related companies to impress Wall Street with earnings or guidance these days, but Teradyne has done just that. Shares of the semiconductor test equipment manufacturer rose 9% to $338.43 on Wednesday after the company late Tuesday reported better-than-expected second-quarter earnings and solid quarterly guidance. Teradyne posted adjusted earnings of $2.47 a share in the second quarter, up from 57 cents a year ago and well above Wall Street’s expectation of $2.09.